Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

JNJ 101.55 +1.21 (1.21%)
price chart
Johnson & Johnson to Remove Formaldehyde From Products
Johnson & Johnson, which makes a range of personal care products like baby shampoo, acne cream and antiwrinkle lotion, announced plans Wednesday to remove a host of potentially harmful chemicals, like formaldehyde, from its line of consumer products ...
Johnson & Johnson Pledges To Purge Controversial Chemicals  NPR (blog)
Johnson & Johnson to Remove Formaldehyde, Other Chemicals from Products  TIME
Related articles »  
Johnson & Johnson Eyes China's Baby Market
Johnson & Johnson is rumored to be considering the acquisition of a local baby-care product vendor Shanghai Elsker in China, a move that could strengthen its foothold in the rapidly-growing Chinese baby-care market.
Johnson & Johnson Announces a Ban on Harmful Chemicals in Products
Johnson & Johnson made the landmark announcement this week that it would ban harmful chemicals from their products. The company has already made the pledge to remove toxic chemicals from its baby products by 2013.
The Real Lesson of Formaldehyde In Baby Shampoo  TIME
What's in Your Shampoo? Formaldehyde?
Related articles »  
Genmab, Johnson & Johnson agree $1.1 billion cancer deal
Janssen Biotech will make an upfront payment of $55 million for the license and Johnson & Johnson Development Corp would invest 475 million Danish crowns ($80 million) in new Genmab shares, the company said.
J&J grabs Genmab's promising leukemia antibody in $1.1B deal  FierceBiotech
Related articles »  
Trials for Alzheimer's Drug Halted After Poor Results
Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer's drug after two clinical trials failed to show that it was effective in patients with mild to moderate forms of the disease.
Lilly Last Hope for Alzheimer's as Pfizer-J&J Bow Out  Bloomberg
Alzheimer's Drug From Pfizer, J&J Fails in Late-Stage Trial  Wall Street Journal
Related articles »  
Johnson & Johnson Still Hates Women With Heavier Than Normal Periods
Last year the internet was in an uproar because Johnson & Johnson discontinued OB Ultra Absorbency tampons. By internet, I mean women's sites, of course.
Johnson & Johnson unit recalls bone putty
The health regulator said certain lots of bone putty made by Johnson & Johnson unit Synthes were recalled as there was potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during surgery.
Related articles »  
Johnson & Johnson agrees to pay $181 million to settle multistate litigation ...
Johnson & Johnson will pay $181 million to resolve claims by 36 states that it improperly advertised the antipsychotic drugs Risperdal and Invega, New York Attorney General Eric Schneiderman and the company said.
Here Are The Allegations That Spurred J&J To Pay A $181 Million ...  Business Insider
Johnson Johnson subsidiary to pay record amount to settle off-label ...  Seattle Post Intelligencer (blog)
Related articles »  
Why Berkshire Sold Most Of Its Johnson & Johnson Holdings
We are amazed that Johnson & Johnson (NYSE:JNJ) has seen the recent reversals of fortune that it has endured. We first followed JNJ back in the 1990s, and we remember the company as being able to consistently generate strong profitability, growth, and ...
Related articles »  
Why Did Warren Buffett Sell Johnson & Johnson?
Warren Buffett made lots of headlines when it was disclosed that he had made substantial liquidations of several long-term stock holdings.
Related articles »